Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes (Proxipart)

R

Ramsay Générale de Santé

Status

Enrolling

Conditions

Diabete Type 2

Treatments

Behavioral: Study nurse intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05325710
2021-A00375-36

Details and patient eligibility

About

In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros. This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.

Full description

In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated. since it does not take into account people who are untreated or not diagnosed. However, given the silent nature of the disease, it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. This share decreases with age, falling to 13% among 55-74 year olds. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. Type 2 diabetes, or non-insulin dependent diabetes, is a metabolic disease characterized by a chronic excess of sugar in the blood, affecting both men and women. the Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. The direct consequences are an increase in obesity hich is itself a major risk factor for the development of T2D. Among the risk factors, we also find hyperlipidemia, high blood pressure, high blood sugar fasting, stress, smoking, heredity, family history of diabetes, or gestational diabetes. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.

Enrollment

230 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient, male or female, over the age of 18
  • Patient with a FINDRISC score ≥10 points
  • Beneficiary of a French health insurance system
  • Patient having been informed and having given their consent free, enlightened and written

Exclusion criteria

  • Patient over 75 years old
  • Patient already diagnosed with type 2 diabetes
  • Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
  • Patient participating in another research
  • Patient in period of exclusion from another research always in progress at the time of inclusion.
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.
  • Pregnant, breastfeeding or parturient women.
  • Patient hospitalized without consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

230 participants in 2 patient groups

TD2 standard
Active Comparator group
Description:
Standard TD2 follow-up
Treatment:
Behavioral: Study nurse intervention
TD2+ study Nurse
Experimental group
Description:
Specific study nurse follow-up every 4 months in addition of standard FU.
Treatment:
Behavioral: Study nurse intervention

Trial contacts and locations

1

Loading...

Central trial contact

JF OUDET; MH BArba

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems